<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_UCSC_Safety skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:UCSC/Safety</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="button-custom"><DIV class="tiny-little-menu-word-above-button">MENU</DIV></DIV><UL><LI><A href="https://2017.igem.org/Team:UCSC/Judging">JUDGING</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Notebook">NOTEBOOK</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Human_Practices">HUMAN PRACTICES</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Human_Practices">INTRODUCTION</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Safety">SAFETY</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Applied_Design">APPLIED DESIGN</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Engagement">EDUCATION</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Collaborations">COLLABORATIONS</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/HP/Silver">SILVER</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/HP/Gold_Integrated">GOLD INTEGRATED</A></LI></UL><LI><A href="https://2017.igem.org/Team:UCSC/Project">PROJECT</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Project">THE PROJECT</A></LI><LI><A href="#">METABOLIC ENGINEERING</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Acetaminophen">ACETAMINOPHEN</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/B-12">VITAMIN B<SUB>12</SUB></A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Model">MODELING</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Demonstrate">RESULTS</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Target-Organism">TARGET ORGANISM</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Part_Collection">PARTS</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/InterLab">INTERLAB STUDY</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Team">TEAM</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Team">MEET THE TEAM</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Attributions">ATTRIBUTIONS</A></LI><LI><A href="https://2017.igem.org/Team:UCSC">HOME</A></LI><DIV id="page"><CENTER><H1>SAFETY</H1><DIV class="text-container"><P><SPAN class="firstword">When</SPAN> choosing an organism to help us produce acetaminophen and vitamin B<SUB>12</SUB> we sought out an FDA-approved microbe; however, we resorted to using a non-toxic cyanobacteria, <I>Synechococcus elongatus</I> strain PCC 7942, as a model for <I>Arthrospira platensis</I>. <I>A. platensis</I> is a generally recognized as safe organism and our genes were chosen from bio-safety level 1 (BSL-1) organisms.</P><DIV class="container"><DIV class="row"><H2><B>L A B</B>  SAFETY</H2><DIV class="col-md-5"><P>Proper PPE for BSL-1 organisms are worn in our laboratory. Within the lab space, every person is expected to be wearing gloves, long pants, close-toed shoes, a lab coat, and protective goggles. All personnel also must be accompanied with one other person so that there is no one alone in lab.
          </P></DIV></DIV></DIV><H2><B>P R O J E C T</B>  SAFETY</H2><H3>VITAMIN B<SUB>12</SUB></H3><H4 style="text-align: left;"><B>G E N E S</B>  U S E D:</H4><P style="padding-left: 30px; padding-right: 30px;"><B>I. <I>ssuE</I></B> --&gt; produces FMN reductase
 
          Organism: <I>Synechoccocous elongatus</I> strain PCC 7002
          
          Biosafety <B>Level I</B>
 
          The synthesis of 5,6-DMB first requires the presence of reduced flavin mononucleotide (FMNH<SUB>2</SUB>). FMNH<SUB>2</SUB> is reduced from flavin mononucleotide (FMN) by FMN reductase, which is encoded with the <I>ssuE</I> gene<SUP>[19,20]</SUP>.
          

          FMNH<SUB>2</SUB> + NADP<SUP>+</SUP> = FMN + NADPH
          <B>II. <I>bluB</I></B> --&gt; 5,6-DMB synthase
          

          Organism: <I>Sinorhizobium meliloti</I> 1021
          
          Biosafety <B>Level I</B></P><H3>ACETAMINOPHEN</H3><H4 style="text-align: left;"><B>G E N E S</B>  U S E D:</H4><P style="padding-left: 30px; padding-right: 30px;"><B>I. <I>4ABH</I></B> --&gt; 4-aminophenol
 
          Organism: <I>Agaricus bisporus</I>
          Biosafety <B>Level I</B><B>II. <I>nhoA</I></B> --&gt; converts 4-aminophenol into acetaminophen
          

          Organism: <I>Escherichia coli</I>
          Biosafety <B>Level I</B></P><DIV class="container"><DIV class="container"><DIV class="reference-list"><LI>[19] R. Caspi, T. Altman, J. M. Dale, K. Dreher, C. A. Fulcher, F. Gilham, P. Kaipa, A. S. Karthikeyan, A. Kothari, M. Krummenacker, M. Latendresse, L. A. Mueller, S. Paley, L. Popescu, A. Pujar, A. G. Shearer, P. Zhang, and P. D. Karp, “The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases,” Nucleic Acids Research, vol. 38, pp. D473–D479, Jan. 2010.</LI><LI>[20] “ssuE - FMN reductase (NADPH) - Escherichia coli (strain K12) - ssuE gene &amp; protein.”</LI></DIV></DIV></DIV></DIV><FOOTER><DIV class="footer-box"><DIV class="col-md-5" style="padding-bottom: 40px;"><CENTER><DIV class="footer-section-title">S P O N S O R S</DIV><DIV class="col-md-2" style="padding-bottom: 40px;"><CENTER><DIV class="footer-section-title">S O C I A L </DIV></CENTER></DIV><DIV class="col-md-4" style="padding-bottom: 40px;"><CENTER><DIV class="footer-section-title">C O N T A C T</DIV><DIV class="address-of-our-team"><SPAN>Jack Baskin School of Engineering
    		University of California, Santa Cruz
    		1156 High Street
    		Santa Cruz, California, 95064</SPAN></DIV></CENTER></DIV></CENTER></DIV></DIV></FOOTER></CENTER></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>